Text Registration
Copyright Title
Mitochondria-Targeted Therapy for Metastatic Melanoma
Status
Published
on 23 Mar 2018
Year of Creation
2015
Copyright Claimant
Kyle Christopher Kloepping
Registration Number
TX0008612893
on 23 Mar 2018Copyright Summary
The U.S. Copyright record (Registration Number: TX0008612893) dated 23 Mar 2018, pertains to an electronic file (eService) titled "Mitochondria-Targeted Therapy for Metastatic Melanoma" created in 2015. The copyright holder is Kyle Christopher Kloepping, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Kyle Christopher Kloepping.
Application Details
Registration Number
TX0008612893
Registration Date
3/23/2018
Year of Creation
2015
Agency Marc Code
DLC-CO
Record Status
New
Physical Description
Electronic file (eService)
First Publication Nation
United States
Notes
Rights Note: Mark Dill, ProQuest-CSA, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600, disspub@proquest.com
Statements
Application Title Statement: Mitochondria-Targeted Therapy for Metastatic Melanoma
Author Statement: Kyle Christopher Kloepping Citizenship: not known Authorship: text
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.